市場調査レポート

商品コード

1483115

核酸分離と精製市場の評価：製品別、タイプ別、方法別、用途別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Nucleic Acid Isolation and Purification Market Assessment, By Product, By Type, By Method, By Applications, By End-users, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年05月23日
発行: Market Xcel - Markets and Data
ページ情報: 英文 233 Pages
納期: 3～5営業日

カスタマイズ可能

価格

PDF & Excel Printable (Single User License)

USD 4,800 691,584円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 6,000 864,480円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,500 1,224,680円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.08円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の核酸分離と精製の市場規模は、予測期間の2024年～2031年のCAGRが8.06%になると予測され、2023年の48億9,000万米ドルから2031F年には91億米ドルに成長するとみられています。同市場の成長を支えているのは、ヘルスケア分野の拡大、遺伝性疾患の負担増、核酸分離と精製の技術進歩、分子診断への要求の高まりです。

世界の様々な地域で、がんを含む様々な遺伝性疾患の負担が増加していることは、世界の核酸分離と精製市場の大きな動向の一つです。米国国立がん研究所の推計によると、2022年には世界中で約2,000万人の新規がん症例が報告されました。2040年までに、この数は 2,990万人に増加すると予想されています。核酸を調査することは、研究者がそのような病気についての洞察を得るのに役立つため、この増加は、研究機関からの核酸分離と精製機器およびキットへの要求を推進しています。研究は、このような疾患の背後にある遺伝的メカニズムの理解向上に役立ち、新規介入、早期診断テスト、新規治療法の開発を可能にします。

自動核酸分離と精製システムの開発を含む技術の進歩により、世界の核酸分離と精製市場規模が拡大しています。このような装置の開発への取り組みが活発化しているのは、高純度のサンプルを処理する一方で、スループット、精度、再現性の向上に対する要求が高まっているためです。

当レポートでは、世界の核酸分離と精製市場について調査し、市場の概要とともに、製品タイプ別、方法別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1.Global Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
Figure 2.Global Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
Figure 3.Global Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
Figure 4.Global Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
Figure 5.Global Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
Figure 6.Global Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
Figure 7.Global Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
Figure 8.Global Nucleic Acid Isolation and Purification Market Share (%), By Region, 2017-2031F
Figure 9.North America Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
Figure 10.North America Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
Figure 11.North America Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
Figure 12.North America Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
Figure 13.North America Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
Figure 14.North America Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
Figure 15.North America Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
Figure 16.North America Nucleic Acid Isolation and Purification Market Share (%), By Country, 2017-2031F
Figure 17.United States Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
Figure 18.United States Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
Figure 19.United States Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
Figure 20.United States Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
Figure 21.United States Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
Figure 22.United States Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
Figure 23.United States Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
Figure 24.Canada Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
Figure 25.Canada Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
Figure 26.Canada Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
Figure 27.Canada Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
Figure 28.Canada Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
Figure 29.Canada Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
Figure 30.Canada Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
Figure 31.Mexico Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
Figure 32.Mexico Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
Figure 33.Mexico Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
Figure 34.Mexico Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
Figure 35.Mexico Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
Figure 36.Mexico Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
Figure 37.Mexico Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
Figure 38.Europe Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
Figure 39.Europe Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
Figure 40.Europe Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
Figure 41.Europe Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
Figure 42.Europe Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
Figure 43.Europe Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
Figure 44.Europe Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
Figure 45.Europe Nucleic Acid Isolation and Purification Market Share (%), By Country, 2017-2031F
Figure 46.Germany Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
Figure 47.Germany Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
Figure 48.Germany Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
Figure 49.Germany Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
Figure 50.Germany Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
Figure 51.Germany Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
Figure 52.Germany Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
Figure 53.France Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
Figure 54.France Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
Figure 55.France Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
Figure 56.France Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
Figure 57.France Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
Figure 58.France Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
Figure 59.France Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
Figure 60.Italy Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
Figure 61.Italy Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
Figure 62.Italy Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
Figure 63.Italy Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
Figure 64.Italy Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
Figure 65.Italy Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
Figure 66.Italy Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
Figure 67.United Kingdom Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
Figure 68.United Kingdom Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
Figure 69.United Kingdom Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
Figure 70.United Kingdom Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
Figure 71.United Kingdom Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
Figure 72.United Kingdom Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
Figure 73.United Kingdom Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
Figure 74.Russia Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
Figure 75.Russia Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
Figure 76.Russia Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
Figure 77.Russia Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
Figure 78.Russia Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
Figure 79.Russia Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
Figure 80.Russia Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
Figure 81.Netherlands Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
Figure 82.Netherlands Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
Figure 83.Netherlands Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
Figure 84.Netherlands Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
Figure 85.Netherlands Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
Figure 86.Netherlands Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
Figure 87.Netherlands Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
Figure 88.Spain Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
Figure 89.Spain Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
Figure 90.Spain Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
Figure 91.Spain Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
Figure 92.Spain Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
Figure 93.Spain Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
Figure 94.Spain Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
Figure 95.Turkey Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
Figure 96.Turkey Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
Figure 97.Turkey Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
Figure 98.Turkey Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
Figure 99.Turkey Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
Figure 100.Turkey Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
Figure 101.Turkey Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
Figure 102.Poland Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
Figure 103.Poland Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
Figure 104.Poland Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
Figure 105.Poland Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
Figure 106.Poland Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
Figure 107.Poland Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
Figure 108.Poland Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
Figure 109.South America Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
Figure 110.South America Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
Figure 111.South America Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
Figure 112.South America Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
Figure 113.South America Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
Figure 114.South America Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
Figure 115.South America Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
Figure 116.South America Nucleic Acid Isolation and Purification Market Share (%), By Country, 2017-2031F
Figure 117.Brazil Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
Figure 118.Brazil Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
Figure 119.Brazil Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
Figure 120.Brazil Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
Figure 121.Brazil Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
Figure 122.Brazil Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
Figure 123.Brazil Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
Figure 124.Argentina Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
Figure 125.Argentina Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
Figure 126.Argentina Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
Figure 127.Argentina Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
Figure 128.Argentina Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
Figure 129.Argentina Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
Figure 130.Argentina Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
Figure 131.Asia-Pacific Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
Figure 132.Asia-Pacific Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
Figure 133.Asia-Pacific Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
Figure 134.Asia-Pacific Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
Figure 135.Asia-Pacific Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
Figure 136.Asia-Pacific Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
Figure 137.Asia- Pacific Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
Figure 138.Asia-Pacific Nucleic Acid Isolation and Purification Market Share (%), By Country, 2017-2031F
Figure 139.India Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
Figure 140.India Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
Figure 141.India Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
Figure 142.India Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
Figure 143.India Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
Figure 144.India Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
Figure 145.India Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
Figure 146.China Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
Figure 147.China Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
Figure 148.China Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
Figure 149.China Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
Figure 150.China Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
Figure 151.China Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
Figure 152.China Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
Figure 153.Japan Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
Figure 154.Japan Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
Figure 155.Japan Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
Figure 156.Japan Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
Figure 157.Japan Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
Figure 158.Japan Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
Figure 159.Japan Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
Figure 160.Australia Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
Figure 161.Australia Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
Figure 162.Australia Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
Figure 163.Australia Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
Figure 164.Australia Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
Figure 165.Australia Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
Figure 166.Australia Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
Figure 167.Vietnam Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
Figure 168.Vietnam Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
Figure 169.Vietnam Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
Figure 170.Vietnam Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
Figure 171.Vietnam Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
Figure 172.Vietnam Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
Figure 173.Vietnam Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
Figure 174.South Korea Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
Figure 175.South Korea Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
Figure 176.South Korea Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
Figure 177.South Korea Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
Figure 178.South Korea Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
Figure 179.South Korea Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
Figure 180.South Korea Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
Figure 181.Indonesia Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
Figure 182.Indonesia Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
Figure 183.Indonesia Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
Figure 184.Indonesia Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
Figure 185.Indonesia Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
Figure 186.Indonesia Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
Figure 187.Indonesia Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
Figure 188.Philippines Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
Figure 189.Philippines Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
Figure 190.Philippines Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
Figure 191.Philippines Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
Figure 192.Philippines Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
Figure 193.Philippines Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
Figure 194.Philippines Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
Figure 195.Middle East & Africa Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
Figure 196.Middle East & Africa Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
Figure 197.Middle East & Africa Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
Figure 198.Middle East & Africa Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
Figure 199.Middle East & Africa Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
Figure 200.Middle East & Africa Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
Figure 201.Middle East & Africa Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
Figure 202.Middle East & Africa Nucleic Acid Isolation and Purification Market Share (%), By Country, 2017-2031F
Figure 203.Saudi Arabia Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
Figure 204.Saudi Arabia Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
Figure 205.Saudi Arabia Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
Figure 206.Saudi Arabia Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
Figure 207.Saudi Arabia Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
Figure 208.Saudi Arabia Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
Figure 209.Saudi Arabia Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
Figure 210.UAE Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
Figure 211.UAE Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
Figure 212.UAE Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
Figure 213.UAE Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
Figure 214.UAE Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
Figure 215.UAE Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
Figure 216.UAE Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
Figure 217.South Africa Nucleic Acid Isolation and Purification Market, By Value, In USD Billion, 2017-2031F
Figure 218.South Africa Nucleic Acid Isolation and Purification Market, By Volume, In Million Units, 2017-2031F
Figure 219.South Africa Nucleic Acid Isolation and Purification Market Share (%), By Product, 2017-2031F
Figure 220.South Africa Nucleic Acid Isolation and Purification Market Share (%), By Type, 2017-2031F
Figure 221.South Africa Nucleic Acid Isolation and Purification Market Share (%), By Method, 2017-2031F
Figure 222.South Africa Nucleic Acid Isolation and Purification Market Share (%), By Applications, 2017-2031F
Figure 223.South Africa Nucleic Acid Isolation and Purification Market Share (%), By End-users, 2017-2031F
Figure 224.By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 225.By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 226.By Method Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 227.By Applications Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 228.By End-users Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 229.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX11353

Global nucleic acid isolation and purification market is projected to witness a CAGR of 8.06% during the forecast period 2024-2031F, growing from USD 4.89 billion in 2023 to USD 9.1 billion in 2031F. The growth of the market is supported by the expansion of healthcare sector, increasing burden of genetic diseases, technological advancements in nucleic acid isolation and purification, and rising requirement from molecular diagnostics.

The increasing burden of various genetic diseases, including cancer, in various regions across the globe is one of the major global nucleic acid isolation and purification market trends. According to the estimates of the National Cancer Institute, in 2022, approximately 20 million new cases of cancer were reported across the globe. By 2040, the number is expected to increase to 29.9 million. The rise is propelling the requirement for nucleic acid isolation and purification instruments and kits from research institutes as studying nucleic acids helps researchers gain insights into such diseases. The research aids in improving the understanding of genetic mechanisms behind such conditions, enabling the development of novel interventions, early diagnostic tests, and new treatments.

Advancements in technology, including the development of automated nucleic acid isolation and purification systems, are bolstering the global nucleic acid isolation and purification market size. Rising efforts to develop such devices can be attributed to the growing requirement for increased throughput, accuracy, and reproducibility while processing samples with a high degree of purity.

Various companies are investing towards the development of modular instruments that are capable of working together with the help of connected software for addressing complete workflows including, extraction, sample preparation, and downstream preparation of nucleic acids that have been purified for several applications. The isolation of high-quality nucleic acids is essential for various downstream applications including genetic engineering, life sciences, forensics, diagnostics, and sequencing.

Expansion of Molecular Diagnostics Sector Boosts Market Demand

The rising requirement for molecular diagnostics is boosting the global demand for nucleic acid isolation and purification. The growing requirement of molecular diagnostics can be attributed to their increasing utilization in guiding patient management, treatment, and diagnosis, particularly in the arena of congenital abnormalities, cancer, and infectious diseases. The rising requirement for molecular diagnostics is supported by the increasing awareness about the benefits offered by personalized medicines and growing prevalence of chronic diseases.

According to the estimates of the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), six out of ten Americans live with at least one chronic health condition. Molecular diagnostics is essential for improving the treatment and diagnosis of a broad range of diseases, resulting in better patient outcomes. Thus, the growing requirement for molecular diagnostics will propel the demand for nucleic acid isolation and purification kits and instruments.

Increasing Emphasis on Research and Development Activities

The rising investments by various organizations towards research and development activities are providing lucrative growth opportunities to the market. Such activities allow the development of novel technologies that support the expansion of the market. For instance, in February 2023, BioEcho Life Sciences announced they had received two new patents from the Japan Patent Office and the United States Patent and Trademark Office. The patent called "Rapid purification of high-quality nucleic acids from biological samples" will aid the company in strengthening its intellectual property portfolio. The EchoLUTION technology developed by the company supports DNA and RNA extraction in a single centrifugation step. The patent strengthens the company's position as a transformation driver for various processes in biopharmaceutical research, academics, and molecular diagnostics. Such developments are expected to support the expansion of the market in the coming years.

North America Accounts for a Significant Market Share

The expansion of the market in North America is supported by the increasing investments by the government and research institutes towards molecular biology and genomics, rapid growth of the pharmaceutical and biotechnology sectors in the region, and strong presence of various market players. The consistent research and development efforts coupled with the presence of a favorable regulatory framework is boosting the growth of North America nucleic acid isolation and purification market. The increasing investments in biotechnology sector is expected to boost the requirement for nucleic acid isolation and purification kits and instruments in the coming years. In 2023, the biotech firms in the United States attracted a total funding of USD 56.79 billion. The rising requirement for personalized medicines due to the rapid expansion of the healthcare sector is another major factor augmenting the growth of the market in the region.

DNA Isolation and Purification Expected to Witness Significant Growth

The expansion of the segment can be attributed to the importance of DNA extraction in studying the different genetic causes associated with a disease. It is important for developing diagnostics and drugs, carrying out sequencing genomes, and detecting viruses and bacteria, among others. The introduction of novel products by various leading market players is another major factor supporting the expansion of the segment. In May 2024, One BioMed launched X8 HMW DNA Cartridge Kits. The kits are capable of extracting high molecular weight (HMW) DNA in an automated manner, for usage in genome assembly and long-read sequencing. The kit is the world's first automated platform to extract high molecular weight DNA from various sample types such as cell culture, peripheral blood mononuclear cells, bacteria, etc. The company's patented Xceler8 technology is expected to redefine nucleic acid extraction by utilizing a rapid and gentle chemistry-based approach for selectively binding, clustering, and purifying intact DNA with the help of controlled fluidics.

Hospitals and Diagnostic Centers Hold Significant Market Share

The rising requirement for nucleic acid isolation and purification instruments and kits from the hospitals and diagnostic centers can be attributed to the growing prevalence of various genetic diseases and disorders across the globe. According to the estimates of the National Health, Lung, and Blood Institute, in a year, sickle cell amenia affects approximately 20 million individuals across the globe. Hospitals and diagnostic centers are heavily investing in advanced and innovative diagnostic equipment to enhance the care and services provided to the patients. RNA and DNA purification and isolation techniques are some of the efficient techniques that are deployed for diagnosing various genetic diseases inducing cystic fibrosis, sickle cell anemia, down's syndrome, and others. Furthermore, the growing emergence of new diagnostic assays and rising requirement for point-of-care testing is augmenting the demand for nucleic acid isolation and purification processes that can be easily incorporated with the diagnostic workflow, providing lucrative growth opportunities to the market.

Future Market Scenario (2024 - 2031F)

According to nucleic acid isolation and purification market analysis, the market is expected to witness significant growth in the coming years due to the increasing popularity of nucleic acid-based diagnostics and the rapid expansion of the pipeline for RNA therapeutics. The increasing utilization of sequencing platforms for clinical diagnostics and rising research and development activities will further expand the market. The growing number of genetic and infectious diseases is expected to boost the demand for nucleic acid isolation and purification instruments and kits for diagnostic applications.

Key Players Landscape and Outlook

The major players in the nucleic acid isolation and purification market are QIAGEN N.V., Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., and Danaher Corporation. The introduction of novel instruments and technologies by leading market players is expected to provide lucrative growth opportunities for the market. In December 2023, Thermo Fisher Scientific Inc. launched an automated nucleic acid purification instrument called Thermo Scientific KingFisher Apex Dx. The product is expected to provide laboratories with in vitro diagnostic regulation approved sample prepared solutions for boosting the confidence in downstream results. The system automates the extraction of RNA, DNA, protein, and cell samples by offering IVD and RUO software modes.

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Nucleic Acid Isolation and Purification Market Outlook, 2017-2031F

4.1.Market Size & Forecast
- 4.1.1.By Value
- 4.1.2.By Volume
4.2.By Product
- 4.2.1.Instruments
  - 4.2.1.1.Manual
  - 4.2.1.2.Automatic
- 4.2.2.Kits and Reagents
4.3.By Type
- 4.3.1.RNA Isolation and Purification
  - 4.3.1.1.mRNA Isolation and Purification
  - 4.3.1.2.miRNA Isolation and Purification
  - 4.3.1.3.Total RNA Isolation and Purification
  - 4.3.1.4.Others
- 4.3.2.DNA Isolation and Purification
  - 4.3.2.1.Genomic DNA Isolation and Purification
  - 4.3.2.2.Viral DNA Isolation and Purification
  - 4.3.2.3.Plasmid DNA Isolation and Purification
  - 4.3.2.4.Others
4.4.By Method
- 4.4.1.Column-based
- 4.4.2.Reagent-based
- 4.4.3.Magnetic Beads
- 4.4.4.Others
4.5.By Applications
- 4.5.1.Diagnostics
- 4.5.2.Precision Medicine
- 4.5.3.Drug Discovery and Development
- 4.5.4.Agriculture and Animal Research
- 4.5.5.Others
4.6.By End-users
- 4.6.1.Academic and Research Institutes
- 4.6.2.Hospitals and Diagnostic Centers
- 4.6.3.Contract Research Organizations
- 4.6.4.Pharmaceutical and Biotechnology Companies
- 4.6.5.Others
4.7.By Region
- 4.7.1.North America
- 4.7.2.South America
- 4.7.3.Europe
- 4.7.4.Asia-Pacific
- 4.7.5.Middle East and Africa
4.8.By Company Market Share (%), 2023

5.Global Nucleic Acid Isolation and Purification Market Outlook, By Region, 2017-2031F

5.1.North America*
- 5.1.1.Market Size & Forecast
  - 5.1.1.1.By Value
  - 5.1.1.2.By Volume
- 5.1.2.By Product
  - 5.1.2.1.Instruments
    - 5.1.2.1.1.Manual
    - 5.1.2.1.2.Automatic
  - 5.1.2.2.Kits and Reagents
- 5.1.3.By Type
  - 5.1.3.1.RNA Isolation and Purification
    - 5.1.3.1.1.mRNA Isolation and Purification
    - 5.1.3.1.2.miRNA Isolation and Purification
    - 5.1.3.1.3.Total RNA Isolation and Purification
    - 5.1.3.1.4.Others
  - 5.1.3.2.DNA Isolation and Purification
    - 5.1.3.2.1.Genomic DNA Isolation and Purification
    - 5.1.3.2.2.Viral DNA Isolation and Purification
    - 5.1.3.2.3.Plasmid DNA Isolation and Purification
    - 5.1.3.2.4.Others
- 5.1.4.By Method
  - 5.1.4.1.Column-based
  - 5.1.4.2.Reagent-based
  - 5.1.4.3.Magnetic Beads
  - 5.1.4.4.Others
- 5.1.5.By Applications
  - 5.1.5.1.Diagnostics
  - 5.1.5.2.Precision Medicine
  - 5.1.5.3.Drug Discovery and Development
  - 5.1.5.4.Agriculture and Animal Research
  - 5.1.5.5.Others
- 5.1.6.By End-users
  - 5.1.6.1.Academic and Research Institutes
  - 5.1.6.2.Hospitals and Diagnostic Centers
  - 5.1.6.3.Contract Research Organizations
  - 5.1.6.4.Pharmaceutical and Biotechnology Companies
  - 5.1.6.5.Others
- 5.1.7.United States*
  - 5.1.7.1.Market Size & Forecast
    - 5.1.7.1.1.By Value
    - 5.1.7.1.2.By Volume
  - 5.1.7.2.By Product
    - 5.1.7.2.1.Instruments
      - 5.1.7.2.1.1.Manual
      - 5.1.7.2.1.2.Automatic
    - 5.1.7.2.2.Kits and Reagents
  - 5.1.7.3.By Type
    - 5.1.7.3.1.RNA Isolation and Purification
      - 5.1.7.3.1.1.mRNA Isolation and Purification
      - 5.1.7.3.1.2.miRNA Isolation and Purification
      - 5.1.7.3.1.3.Total RNA Isolation and Purification
      - 5.1.7.3.1.4.Others
    - 5.1.7.3.2.DNA Isolation and Purification
      - 5.1.7.3.2.1.Genomic DNA Isolation and Purification
      - 5.1.7.3.2.2.Viral DNA Isolation and Purification
      - 5.1.7.3.2.3.Plasmid DNA Isolation and Purification
      - 5.1.7.3.2.4.Others
  - 5.1.7.4.By Method
    - 5.1.7.4.1.Column-based
    - 5.1.7.4.2.Reagent-based
    - 5.1.7.4.3.Magnetic Beads
    - 5.1.7.4.4.Others
  - 5.1.7.5.By Applications
    - 5.1.7.5.1.Diagnostics
    - 5.1.7.5.2.Precision Medicine
    - 5.1.7.5.3.Drug Discovery and Development
    - 5.1.7.5.4.Agriculture and Animal Research
    - 5.1.7.5.5.Others
  - 5.1.7.6.By End-users
    - 5.1.7.6.1.Academic and Research Institutes
    - 5.1.7.6.2.Hospitals and Diagnostic Centers
    - 5.1.7.6.3.Contract Research Organizations
    - 5.1.7.6.4.Pharmaceutical and Biotechnology Companies
    - 5.1.7.6.5.Others
- 5.1.8.Canada
- 5.1.9.Mexico

All segments will be provided for all regions and countries covered

5.2.Europe
- 5.2.1.Germany
- 5.2.2.France
- 5.2.3.Italy
- 5.2.4.United Kingdom
- 5.2.5.Russia
- 5.2.6.Netherlands
- 5.2.7.Spain
- 5.2.8.Turkey
- 5.2.9.Poland
5.3.Asia-Pacific
- 5.3.1.India
- 5.3.2.China
- 5.3.3.Japan
- 5.3.4.Australia
- 5.3.5.Vietnam
- 5.3.6.South Korea
- 5.3.7.Indonesia
- 5.3.8.Philippines
5.4.South America
- 5.4.1.Brazil
- 5.4.2.Argentina
5.5.Middle East and Africa
- 5.5.1.Saudi Arabia
- 5.5.2.UAE
- 5.5.3.South Africa

6.Market Mapping, 2023

6.1.By Product
6.2.By Type
6.3.By Method
6.4.By Applications
6.5.By End-users
6.6.By Region

7.Macro Environment and Industry Structure

7.1.Supply Demand Analysis
7.2.Import Export Analysis
7.3.Value Chain Analysis
7.4.PESTEL Analysis
- 7.4.1.Political Factors
- 7.4.2.Economic System
- 7.4.3.Social Implications
- 7.4.4.Technological Advancements
- 7.4.5.Environmental Impacts
- 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5.Porter's Five Forces Analysis
- 7.5.1.Supplier Power
- 7.5.2.Buyer Power
- 7.5.3.Substitution Threat
- 7.5.4.Threat from New Entrant
- 7.5.5.Competitive Rivalry

8.Market Dynamics

8.1.Growth Drivers
8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

9.1.Patent Landscape
9.2.Regulatory Approvals
9.3.Innovations/Emerging Technologies

10.Key Players Landscape

10.1.Competition Matrix of Top Five Market Leaders
10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4.SWOT Analysis (For Five Market Players)
10.5.Patent Analysis (If Applicable)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

13.1.QIAGEN N.V.
- 13.1.1.Company Details
- 13.1.2.Key Management Personnel
- 13.1.3.Products & Services
- 13.1.4.Financials (As reported)
- 13.1.5.Key Market Focus & Geographical Presence
- 13.1.6.Recent Developments
13.2.Agilent Technologies, Inc.
13.3.Thermo Fisher Scientific Inc.
13.4.Bio-Rad Laboratories, Inc.
13.5.Danaher Corporation
13.6.GE HealthCare Technologies, Inc.
13.7.Merck KGaA
13.8.F. Hoffmann-La Roche Ltd
13.9.Promega Corporation
13.10.Takara Bio, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

核酸分離と精製市場の評価：製品別、タイプ別、方法別、用途別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Nucleic Acid Isolation and Purification Market Assessment, By Product, By Type, By Method, By Applications, By End-users, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界の核酸分離と精製市場の見通し、2017年～2031年

第5章世界の核酸分離と精製市場の見通し、地域別、2017年～2031年

第6章市場マッピング、2023年

第7章マクロ環境と産業構造

第8章市場力学

第9章規制枠組みとイノベーション

第10章主要参入企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要参入企業の見通し

第14章戦略的提言

第15章お問い合わせと免責事項

List of Tables

List of Figures

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Nucleic Acid Isolation and Purification Market Outlook, 2017-2031F

5.Global Nucleic Acid Isolation and Purification Market Outlook, By Region, 2017-2031F

6.Market Mapping, 2023

7.Macro Environment and Industry Structure

8.Market Dynamics

9.Regulatory Framework and Innovation

10.Key Players Landscape

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

14.Strategic Recommendations

15.About Us & Disclaimer

核酸分離と精製市場の評価：製品別、タイプ別、方法別、用途別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Nucleic Acid Isolation and Purification Market Assessment, By Product, By Type, By Method, By Applications, By End-users, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の核酸分離と精製市場の見通し、2017年～2031年

第5章 世界の核酸分離と精製市場の見通し、地域別、2017年～2031年

第6章 市場マッピング、2023年

第7章 マクロ環境と産業構造

第8章 市場力学

第9章 規制枠組みとイノベーション

第10章 主要参入企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要参入企業の見通し

第14章 戦略的提言

第15章 お問い合わせと免責事項

List of Tables

List of Figures

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Nucleic Acid Isolation and Purification Market Outlook, 2017-2031F

5.Global Nucleic Acid Isolation and Purification Market Outlook, By Region, 2017-2031F

6.Market Mapping, 2023

7.Macro Environment and Industry Structure

8.Market Dynamics

9.Regulatory Framework and Innovation

10.Key Players Landscape

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

14.Strategic Recommendations

15.About Us & Disclaimer

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界の核酸分離と精製市場の見通し、2017年～2031年

第5章世界の核酸分離と精製市場の見通し、地域別、2017年～2031年

第6章市場マッピング、2023年

第7章マクロ環境と産業構造

第8章市場力学

第9章規制枠組みとイノベーション

第10章主要参入企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要参入企業の見通し

第14章戦略的提言

第15章お問い合わせと免責事項